Incidence of pediatric inflammatory bowel disease (IBD) in one region of Denmark nearly quadrupled over four decades, ...

New ECCO dietary therapy guidelines for IBD clarify the role of enteral nutrition, Mediterranean diet, supplements, and RD ...

Duvakitug is currently in phase 3 trials for ulcerative colitis and Crohn’s disease.

Two weeks after Teva touted promising long-term data for its Sanofi-partnered bowel disease drug, the Israeli pharma ...

Blackstone Life Sciences will provide $400 million to support development of duvakitug, a human monoclonal antibody targeting TL1ADuvakitug is ...

New York, NY, and Riyadh, Saudi Arabia [March 3, 2026] — Mount Sinai and King Saud University Medical City in Riyadh, Saudi Arabia, today announced a three-year collaboration aimed at better ...

OSE Immunotherapeutics has kicked off a strategic realignment initiative that involves deprioritizing the AbbVie-partnered OSE-230 and focusing its resources on the late-stage development of its ...

Kyverna is leading other companies in the CAR-T sector. Their flagship product is KYV-101. It takes cells from the patient and engineers them with CD28 stimulation. Kyverna’s KYSA-8 delivered data on ...

In an open-label study of 29 men, including patients with ulcerative colitis and Crohn’s disease in remission, 6 g per day of curcumin for eight weeks led to modest, transient shifts in gut microbiota ...

Approximately 60,000 Danes live with chronic inflammatory bowel disease. Some experience limited discomfort, while others go ...

Chronic inflammatory bowel disease is a serious and unpredictable disease, and many people with the disease today receive either too little or too much treatment. A new Danish study opens up the ...

Abivax is developing obefazimod as a potential treatment for ulcerative colitis (UC). There are plenty of medicines in this ...